Article

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis

2023-06-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and a leading cause of neurological disability in young adults. Clinical presentation and disease course are highly heterogeneous. Typically, disease progression occurs over time and is characterized by the gradual accumulation of disability. The risk of developing MS is driven by complex int...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 49f88951-72d2-52a7-8e31-077f8236ea47
DOI: 10.1101/2023.06.26.23291875

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisDOI 10.1101/2023.06.26.23291875Read

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisSemantic proximity Read

Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker PotentialSemantic proximity Read

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.Semantic proximity Read

Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunitySemantic proximity Read

Changes in Gut Microbiota in Patients with Multiple Sclerosis Based on 16s rRNA Gene Sequencing Technology: A Review and Meta-AnalysisSemantic proximity Read

Meta-analysis identifies common gut microbiota signatures in patients with multiple sclerosisSemantic proximity Read

The gut microbiota in multiple sclerosis varies with disease activitySemantic proximity Read

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”Semantic proximity Read

Meta-analysis identifies common gut microbiota associated with multiple sclerosisSemantic proximity Read

Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.Semantic proximity Read

Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot studySemantic proximity Read

Alterations of the human gut microbiome in multiple sclerosisSemantic proximity Read